אונדאנסטרון - פרזניוס ישראל - עברית - Ministry of Health

אונדאנסטרון - פרזניוס

neopharm (israel) 1996 ltd - ondansetron as hydrochloride dihydrate - תמיסה להזרקה - ondansetron as hydrochloride dihydrate 2 mg/ml - ondansetron - ondansetron - adults:for the mangement of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy.for the prevention and treatment of post-operative nausea and vomiting (ponv).paediatric population:for the mangement of chemotherapy-induced nausea and vomiting (cinv) in children aged ? 6 months, and for the prevention and treatment of ponv in children aged ? 2 years.

מידרו תה ישראל - עברית - Ministry of Health

מידרו תה

neopharm (israel) 1996 ltd - sennae folium - תה - sennae folium 75 % - senna glycosides - senna glycosides - laxative.

סינרייז ישראל - עברית - Ministry of Health

סינרייז

neopharm cure (2005) ltd - c - 1 esterase inhibitor human 500 units - lyophilized powder for solution for injection - c1-inhibitor - treatment and pre-procedure prevention of angioedema attacks in adults and adolescents with hereditary angioedema (hae). routine prevention of angioedema attacks in adults and adolescents with severe and recurrent attacks of hereditary angioedema (hae), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.

צפאזולין - פרזניוס ישראל - עברית - Ministry of Health

צפאזולין - פרזניוס

neopharm (israel) 1996 ltd - cefazolin as sodium - אבקה להכנת תמיסה לזריקה - cefazolin as sodium 1000 mg - cefazolin - cefazolin - cefazolin - fresenius is indicated in the treatment of serious infections due to susceptible micro-organisms.

צפורוקסים - פרזניוס 750 מג ישראל - עברית - Ministry of Health

צפורוקסים - פרזניוס 750 מג

neopharm (israel) 1996 ltd - cefuroxime as sodium salt - אבקה להכנת תמיסה לזריקה - cefuroxime as sodium salt 750 mg - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible micro-organisms

צפורוקסים - פרזניוס 1500 מג ישראל - עברית - Ministry of Health

צפורוקסים - פרזניוס 1500 מג

neopharm (israel) 1996 ltd - cefuroxime as sodium salt - אבקה להמסה להזרקה\אינפוזיה - cefuroxime as sodium salt 1500 mg - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible micro-organisms

צפטריאקסון - פרזניוס ישראל - עברית - Ministry of Health

צפטריאקסון - פרזניוס

neopharm (israel) 1996 ltd - ceftriaxone as sodium - אבקה להמסה להזרקה\אינפוזיה - ceftriaxone as sodium 1000 mg/vial - ceftriaxone - ceftriaxone - long-acting, broad spectrum cephalosporin, for the treatment of infections caused by susceptible organisms.

בוקולאם 2.5 מ"ג ישראל - עברית - Ministry of Health

בוקולאם 2.5 מ"ג

neopharm cure (2005) ltd - midazolam as hydrochloride 2.5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.

בוקולאם 5 מ"ג ישראל - עברית - Ministry of Health

בוקולאם 5 מ"ג

neopharm cure (2005) ltd - midazolam as hydrochloride 5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.

בוקולאם 7.5 מ"ג ישראל - עברית - Ministry of Health

בוקולאם 7.5 מ"ג

neopharm cure (2005) ltd - midazolam as hydrochloride 7.5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.